Back to Agenda
LS08 How RWE Affects Decision Making During the COVID-19 Pandemic
Session Chair(s)
Yoshiaki Uyama, PHD, MS, RPH
Associate Executive Director, Regulatory Science Center, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Maria Gordillo-Marañon
, European Medicines Agency, Netherlands
Chieko Ishiguro, PHD, MPH
Section Chief of Clinical Epidemiology, Department of Data Science, National Center for Global Health and Medicine, Japan
Have an account?